CDK12 and central nervous system cancer: The specific mechanism involves METTL3 stabilizing the mRNAs of BUD13 and CDK12, leading to their overexpression, which in turn promotes the phosphorylation of MBNL1 and facilitates the VM process in gliomas (122).